Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

President

Chief Executive Officer

Chief Medical Officer

President and COO

General Counsel and Secretary

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. In addition, Allakos Inc. is conducting preclinical studies for AK007, which polarizes tumor-associated myeloid cells and promotes anti-tumor immunity. The company was incorporated in 2012 and is headquartered in San Carlos, California.

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune e...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-06	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-03-05	Premium	sold (taxes)	Premium	Premium	Premium	President
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-12-04	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-12-04	Premium	sold (taxes)	Premium	Premium	Premium	President
2023-12-04	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-12-04	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-09-05	Premium	sold (taxes)	Premium	Premium	Premium	President
2023-09-05	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-09-05	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-09-05	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-08-16	Premium	sold	Premium	Premium	Premium	-
2023-08-16	Premium	sold	Premium	Premium	Premium	-
2023-08-16	Premium	acquired	Premium	Premium	Premium	-
2023-06-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-06-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-06-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-06-02	Premium	sold (taxes)	Premium	Premium	Premium	President
2023-03-08	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-03-07	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-03-06	Premium	sold (taxes)	Premium	Premium	Premium	President
2023-03-03	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-03-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-01-06	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-01-06	Premium	acquired	Premium	Premium	Premium	President

ALLK - Allakos Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ALLK